Brief: Bayer: Askbio's Viralgen To Supply Drug Product For Regenerate-PD Investigational Gene Therapy Phase Ii Trial
April 20 (Reuters) - BAYER AG BAYGn.DE: BAYER AG - ASKBIO'S VIRALGEN TO SUPPLY COMMERCIAL-SCALE DRUG PRODUCT FOR REGENERATE-PD INVESTIGATIONAL GENE THERAPY PHASE II TRIAL FOR PARKINSON'S DISEASE Source text: [ID:] Further company coverage: [BAYGn.DE] (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bayer AG
See all newsBayer takes a giant leap toward investability
Europe Research Roundup: Barratt Redrow, Ferrari, KPN
Explainer: What does Bayer's US Supreme Court win mean for the thousands of Roundup lawsuits?
Bayer shares soar over 18% after U.S. Supreme Court curbs Roundup lawsuits
US Supreme Court scales back Roundup cancer suits in win for Bayer (updated)